The group from the Institute of Medical Chemistry (GT3) attended last march the 63rd edition of the Annual Congress of the Biophysical Society, held in Baltimore (USA). GT3 presented the results obtained in collaboration with Dr. Carlos A. Villalba-Galea (University of the Pacific, California, USA) related to the development of muscular nicotinic acetylcholine receptors (nAChR) inhibitors based on azobenzene.
Defended thesis
Novel Nrf2 inducers with multitarget activities for the treatment of neurodegenerative diseases.
Click here to go to the thesis. Patrycja Michalska. International PhD Program. Date: 05/04/2019. Financiada por: FPU13/03737. Publications: https://pubmed.ncbi.nlm.nih.gov/?term=Patrycja+Michalska